Skip to main content

Advertisement

SpringerLink
Log in

Elevated expression of EBV and TLRs in the brain is associated with Rasmussen’s encephalitis

  • Research Article
  • Published:
Virologica Sinica

Abstract

Rasmussen’s encephalitis (RE) is a rare pediatric neurological disorder, the etiology of which remains unclear. It has been speculated that the immunopathogenesis of RE involves damage to neurons, which eventually leads to the occurrence of RE. Viral infection may be a critical factor in triggering RE immunopathogenesis. In this study, we analyzed the expression of Epstein-Barr virus (EBV) antigens as well as of Toll-like receptor 3 (TLR3), TLR9, and downstream adapter TIRdomain-containing adapter-inducing interferon-β (TRIF) in the brain tissues of 26 patients with RE and 16 control individuals using immunohistochemistry (IHC). In the RE group, EBV antigens were detected in 53% of individuals at various expression levels. In contrast, there was no detectable EBV antigen expression in control brain tissues. Moreover, we found marked increases in the expression of TLR3, TLR9, and TRIF in the brain tissues of RE patients compared with levels in the control group. Furthermore, among RE cases, EBV expression and high TLR3 expression were associated with more severe brain atrophy. Our results suggest that the elevated expression of EBV and TLRs may be involved in RE occurrence through the activation of downstream molecules.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded rna and activation of nf-kappab by toll-like receptor 3. Nature, 413: 732–738.

    Article  CAS  Google Scholar 

  • Allred DC, Harvey JM, Berardo M, Clark GM. 1998. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol, 11: 155–168.

    CAS  PubMed  Google Scholar 

  • Bauer J, Bien CG, Lassmann H. 2002. Rasmussen’s encephalitis: A role for autoimmune cytotoxic t lymphocytes. Curr Opin Neurol, 15: 197–200.

    Article  Google Scholar 

  • Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H. 2002. Destruction of neurons by cytotoxic t cells: A new pathogenic mechanism in rasmussen’s encephalitis. Ann Neurol, 51: 311–318.

    Article  CAS  Google Scholar 

  • Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE. 2005. Pathogenesis, diagnosis and treatment of rasmussen encephalitis: A european consensus statement. Brain, 128: 454–471.

    Article  CAS  Google Scholar 

  • Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol, 61: 1013–1021.

    Article  CAS  Google Scholar 

  • Chen S, Guan Y, Zhang Y, Qi X, An J, Wang Y, Luan G. 2016. Elevated expression of human papillomavirus antigen in brain tissue of patients with rasmussen’s encephalitis. Epilepsy Res, 126: 119–125.

    Article  CAS  Google Scholar 

  • Eeg-Olofsson O, Bergström T, Andermann F, Andermann E, Olivier A, Rydenhag B. 2004. Herpesviral DNA in brain tissue from patients with temporal lobe epilepsy. Acta Neurol Scand, 109: 169–174.

    Article  CAS  Google Scholar 

  • Farrell MA, Cheng L, Cornford ME, Grody WW, Vinters HV. 1991. Cytomegalovirus and rasmussen’s encephalitis. Lancet, 337: 1551–1552.

    Article  CAS  Google Scholar 

  • Friedman H, Ch’ien L, Parham D. 1977. Virus in brain of child with hemiplegia, hemiconvulsions, and epilepsy. Lancet, 2: 666.

    Article  CAS  Google Scholar 

  • Guan Y, Zhou J, Luan G, Liu X. 2014. Surgical treatment of patients with rasmussen encephalitis. Stereotact Funct Neurosurg, 92: 86–93.

    Article  Google Scholar 

  • Jay V, Becker LE, Otsubo H, Cortez M, Hwang P, Hoffman HJ, Zielenska M. 1995. Chronic encephalitis and epilepsy (rasmussen’s encephalitis): Detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology, 45: 108–117.

    Article  CAS  Google Scholar 

  • Mantegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, Antozzi C, Bernardi G, Granata T. 2002. Antibodies against glur3 peptides are not specific for rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol, 131: 179–185.

    Article  CAS  Google Scholar 

  • Matin N, Tabatabaie O, Falsaperla R, Lubrano R, Pavone P, Mahmood F, Gullotta M, Serra A, Di Mauro P, Cocuzza S, Vitaliti G. 2015. Epilepsy and innate immune system: A possible immunogenic predisposition and related therapeutic implications. Hum Vaccin Immunother, 11: 2021–2029.

    Article  Google Scholar 

  • Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM. 2004. The pathology of rasmussen syndrome: Stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia, 45: 516–526.

    Article  Google Scholar 

  • Power C, Poland SD, Blume WT, Girvin JP, Rice GP. 1990. Cytomegalovirus and rasmussen’s encephalitis. Lancet, 336: 1282–1284.

    Article  CAS  Google Scholar 

  • Rasmussen T, Olszewski J, Lloydsmith D. 1958. Focal seizures due to chronic localized encephalitis. Neurology, 8: 435–445.

    Article  CAS  Google Scholar 

  • Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF, McNamara JO. 1994. Autoantibodies to glutamate receptor glur3 in rasmussen’s encephalitis. Science, 265: 648–651.

    Article  CAS  Google Scholar 

  • Takahashi Y, Matsuda K, Kubota Y, Shimomura J, Yamasaki E, Kudo T, Fukushima K, Osaka H, Akasaka N, Imamura A, Yamada S, Kondo N, Fujiwara T. 2006. Vaccination and infection as causative factors in japanese patients with rasmussen syndrome: Molecular mimicry and hla class i. Clin Dev Immunol, 13: 381–387.

    Article  CAS  Google Scholar 

  • Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, Vincent A, Mathern GW, Cross JH. 2014. Rasmussen’s encephalitis: Clinical features, pathobiology, and treatment advances. Lancet Neurol, 13: 195–205.

    Article  Google Scholar 

  • Verma R, Bharti K. 2017. Toll like receptor 3 and viral infections of nervous system. J Neurol Sci, 372: 40–48.

    Article  CAS  Google Scholar 

  • Walter GF, Renella RR. 1989. Epstein-barr virus in brain and rasmussen’s encephalitis. Lancet, 1: 279–280.

    Article  CAS  Google Scholar 

  • Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, Yao J, Ajani J, Xie K. 2003. Transcription factor sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res, 9: 6371–6380.

    CAS  PubMed  Google Scholar 

  • Wiendl H, Bien CG, Bernasconi P, Fleckenstein B, Elger CE, Dichgans J, Mantegazza R, Melms A. 2001. Glur3 antibodies: Prevalence in focal epilepsy but no specificity for rasmussen’s encephalitis. Neurology, 57: 1511–1514.

    Article  CAS  Google Scholar 

  • Zhang Y, Wang Y, Chen S, Guan Y, Liu C, Li T, Luan G, An J. 2017. Expression of human cytomegalovirus components in the brain tissues of patients with rasmussen’s encephalitis. Virol Sin, 32: 115–121.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the following funds: the National Natural Science Foundation of China (81471957, 81571275, 81671971, and 81701992), the Beijing Municipal Natural Science Foundation (7144217), and the Scientific Research Common Program of Beijing Municipal Commission of Education (KM201610025001).

Author information

Authors and Affiliations

  1. Department of Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China

    Xin Wang, Yisong Wang, Peigang Wang, Dongying Fan & Jing An

  2. Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, 100093, China

    Dong Liu, Yuguang Guan & Guoming Luan

  3. Beijing Key Laboratory of Epilepsy, Beijing, 100093, China

    Tianfu Li & Guoming Luan

  4. Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing, 100093, China

    Guoming Luan & Jing An

Authors
  1. Xin Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yisong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peigang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dongying Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuguang Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tianfu Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Guoming Luan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jing An
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Guoming Luan or Jing An.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Wang, Y., Liu, D. et al. Elevated expression of EBV and TLRs in the brain is associated with Rasmussen’s encephalitis. Virol. Sin. 32, 423–430 (2017). https://doi.org/10.1007/s12250-017-4058-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-017-4058-8

Keywords

Search

Navigation